JOHN BARDI — Lobbyist Profile | Poliscope

JOHN BARDI

Filings

Clients

Firms

Years active

2015–2015

Associated filing income

—

How to read the money

Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.

Clients represented

Client	Filings	Years
OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION, INC.	3	2015

Lobbying firms

Firm	Filings	Years
OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION, INC.	3	2015

Bills explicitly cited in this lobbyist’s assigned issues (12)

No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.

H.R. 2624

Part D Beneficiary Appeals Fairness Act

Client: OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION, INC. · Firm: OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION, INC.

Open original LDA filing ↗

Cited source text

S.1945 - Mental Health Reform Act of 2015, S.481 - Improving Regulatory Transparency for New Medical Therapies Act, S.1893 - Mental Health Awareness and Improvement Act of 2015, H.R.2624 - Helping Families in Mental Health Crisis Act of 2015

H.R. 2624

Part D Beneficiary Appeals Fairness Act

Client: OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION, INC. · Firm: OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION, INC.

Open original LDA filing ↗

Cited source text

Original LDA source filings (3)

Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.

OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION, INC. via OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION, INC.

2015 · third_quarter · 3A

Firm income: —Client expense: $290,000Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

S.1945 - Mental Health Reform Act of 2015, S.481 - Improving Regulatory Transparency for New Medical Therapies Act, S.1893 - Mental Health Awareness and Improvement Act of 2015, H.R.2624 - Helping Families in Mental Health Crisis Act of 2015

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION, INC. via OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION, INC.

Source: Senate LDA